244 related articles for article (PubMed ID: 7512706)
1. Triploid partial molar pregnancy detected through maternal serum alpha-fetoprotein and HCG screening.
Harper MA; Ruiz C; Pettenati MJ; Rao PN
Obstet Gynecol; 1994 May; 83(5 Pt 2):844-6. PubMed ID: 7512706
[TBL] [Abstract][Full Text] [Related]
2. Triploid partial molar pregnancy and fetal neural tube defect detected through Down's syndrome screening.
Quintieri F; Idotta R
Clin Exp Obstet Gynecol; 1996; 23(3):181-3. PubMed ID: 8894330
[TBL] [Abstract][Full Text] [Related]
3. A prospective evaluation of a second-trimester screening test for fetal Down syndrome using maternal serum alpha-fetoprotein, hCG, and unconjugated estriol.
Cheng EY; Luthy DA; Zebelman AM; Williams MA; Lieppman RE; Hickok DE
Obstet Gynecol; 1993 Jan; 81(1):72-7. PubMed ID: 7677967
[TBL] [Abstract][Full Text] [Related]
4. Triploidy identified through second-trimester serum screening.
Huang T; Alberman E; Wald N; Summers AM
Prenat Diagn; 2005 Mar; 25(3):229-33. PubMed ID: 15791661
[TBL] [Abstract][Full Text] [Related]
5. Prenatal screening using maternal serum alpha-fetoprotein, human chorionic gonadotropin, and unconjugated estriol: two-year experience in a health maintenance organization.
McDuffie RS; Haverkamp AD; Stark CF; Haverkamp C; Barth CK
J Matern Fetal Med; 1996; 5(2):70-3. PubMed ID: 8796771
[TBL] [Abstract][Full Text] [Related]
6. Unexplained elevated midtrimester maternal serum levels of alpha fetoprotein, human chorionic gonadotropin, or low unconjugated estriol: recurrence risk and association with adverse perinatal outcome.
Wax JR; Lopes AM; Benn PA; Lerer T; Steinfeld JD; Ingardia CJ
J Matern Fetal Med; 2000; 9(3):161-4. PubMed ID: 10914623
[TBL] [Abstract][Full Text] [Related]
7. 'Dual positivity' for neural tube defects and down syndrome at maternal serum screening: gestational outcome.
Zanini R; Tarantini M; Cerri V; Jacobello C; Bellotti D; Lancetti S; Scalchi S; Groli C; Bianchi UA
Fetal Diagn Ther; 1998; 13(2):106-10. PubMed ID: 9650657
[TBL] [Abstract][Full Text] [Related]
8. First trimester diagnosis of partial mole.
Phupong V; Triratanachat S; Promchainant C; Ultchaswadi P
Arch Gynecol Obstet; 2005 Sep; 272(3):235-7. PubMed ID: 15875207
[TBL] [Abstract][Full Text] [Related]
9. Pre-eclampsia and peripartum cardiomyopathy in molar pregnancy: clinical implication for maternally imprinted genes.
Billieux MH; Petignat P; Fior A; Mhawech P; Blouin JL; Dahoun S; Vassilakos P
Ultrasound Obstet Gynecol; 2004 Apr; 23(4):398-401. PubMed ID: 15065193
[TBL] [Abstract][Full Text] [Related]
10. Effectiveness of combining maternal serum alpha-fetoprotein and hCG in a second-trimester screening program for Down syndrome.
Mooney RA; Peterson CJ; French CA; Saller DN; Arvan DA
Obstet Gynecol; 1994 Aug; 84(2):298-303. PubMed ID: 7518896
[TBL] [Abstract][Full Text] [Related]
11. Eclampsia complicating hydatidiform molar pregnancy with a coexisting, viable fetus. A case report.
Ramsey PS; Van Winter JT; Gaffey TA; Ramin KD
J Reprod Med; 1998 May; 43(5):456-8. PubMed ID: 9610471
[TBL] [Abstract][Full Text] [Related]
12. Maternal serum screening.
Carroll JC
Can Fam Physician; 1994 Oct; 40():1756-64. PubMed ID: 7524838
[TBL] [Abstract][Full Text] [Related]
13. 46,XY,i(21q) identified by maternal serum screening.
Meyers CM; Ghori S; Roberson AE; Blitzer MG; Cohen MM
Md Med J; 1997 Feb; 46(2):88-9. PubMed ID: 9029908
[TBL] [Abstract][Full Text] [Related]
14. Are Down syndrome fetuses detected through maternal serum screening similar to those remaining undetected?
Christiaens GC; Hagenaars AM; Akkerman C; De France HF
Prenat Diagn; 1996 May; 16(5):437-42. PubMed ID: 8844002
[TBL] [Abstract][Full Text] [Related]
15. Prenatal diagnosis of a deletion of 18q in a fetus associated with multiple-marker screen positive results.
Chen CP; Chern SR; Liu FF; Jan SW; Lee CC; Chang YC; Yue CT
Prenat Diagn; 1997 Jun; 17(6):571-6. PubMed ID: 9203216
[TBL] [Abstract][Full Text] [Related]
16. Maternal serum screening for neural tube defects and fetal chromosome abnormalities.
Rose NC; Mennuti MT
West J Med; 1993 Sep; 159(3):312-7. PubMed ID: 7694429
[TBL] [Abstract][Full Text] [Related]
17. Current management of complete and partial molar pregnancy.
Goldstein DP; Berkowitz RS
J Reprod Med; 1994 Mar; 39(3):139-46. PubMed ID: 8035368
[TBL] [Abstract][Full Text] [Related]
18. Maternal serum testing for alpha-fetoprotein and human chorionic gonadotropin in high-risk pregnancies.
Jauniaux E; Gulbis B; Tunkel S; Ramsay B; Campbell S; Meuris S
Prenat Diagn; 1996 Dec; 16(12):1129-35. PubMed ID: 8994249
[TBL] [Abstract][Full Text] [Related]
19. Second-trimester maternal serum alpha-fetoprotein, human chorionic gonadotropin, and unconjugated oestriol after early transvaginal multifetal pregnancy reduction.
Groutz A; Amit A; Yaron Y; Yovel I; Wolman I; Legum C; Lessing JB
Prenat Diagn; 1996 Aug; 16(8):723-7. PubMed ID: 8878282
[TBL] [Abstract][Full Text] [Related]
20. hCG and the free beta-subunit as screening tests for Down syndrome.
Knight GJ; Palomaki GE; Neveux LM; Fodor KK; Haddow JE
Prenat Diagn; 1998 Mar; 18(3):235-45. PubMed ID: 9556040
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]